医麦客新闻 eMedClub News
近日,Altamira Therapeutics宣布与Univercells Group达成合作协议,以评估该公司专有的、基于肽的SemaPhore平台在mRNA疫苗递送方面的应用,SemaPhore平台有望代替LNP递送系统,在mRNA领域中有广泛地应用潜力。如果实验成功,Univercells和Altam...查看全文
F1watch2023-07-05 18:20
F-1/A - Altamira Therapeutics Ltd. (0001601936) (Filer) Filed: 2023-07-05 AccNo: 0001213900-23-054243 Size: 1 MB 网页链接查看全文
F1watch2023-06-17 05:20
F-1 - Altamira Therapeutics Ltd. (0001601936) (Filer) Filed: 2023-06-16 AccNo: 0001213900-23-049716 Size: 500 KB 网页链接查看全文
稳妥的回报将军2023-06-16 09:18
上周多伦多证券交易所创业板(TSXV)涨幅最大的资源股是Solis Minerals、MacArthur Minerals、Altamira Gol、VR Resources和Tier One Silver。虽然大盘The S&P/TSX Venture Composite Index (INDEXTSI:JX)上周保持平稳,周五(6月9日)收于610.02点,但领涨的一只资源股的股价在短短五个交易日...查看全文
F1watch2023-06-02 04:40
F-1 - Altamira Therapeutics Ltd. (0001601936) (Filer) Filed: 2023-06-01 AccNo: 0001213900-23-045058 Size: 351 KB 网页链接查看全文
医麦客2023-04-15 07:36
2023年4月15日/医麦客新闻 eMedClub News/--mRNA疫苗技术已发展数十年,研究历史可追溯至20世纪60年代,近两年来疫情的爆发及大流行大大加快了mRNA技术的成熟。目前上市的mRNA产品仅新冠疫苗一类,其他产品仍在临床开发中。近年来的临床研究已表明,mRNA疫苗在疾病预防和肿瘤治疗等多个领域具有巨...查看全文
F1watch2023-03-27 22:40
F-1/A - Altamira Therapeutics Ltd. (0001601936) (Filer) Filed: 2023-03-27 AccNo: 0001213900-23-023002 Size: 15 MB 网页链接查看全文
F1watch2023-03-13 21:20
F-1/A - Altamira Therapeutics Ltd. (0001601936) (Filer) Filed: 2023-03-13 AccNo: 0001213900-23-019406 Size: 15 MB 网页链接查看全文
F1watch2023-03-02 02:10
F-1/A - Altamira Therapeutics Ltd. (0001601936) (Filer) Filed: 2023-03-01 AccNo: 0001213900-23-016044 Size: 15 MB 网页链接查看全文
F1watch2023-03-01 05:20
F-1/A - Altamira Therapeutics Ltd. (0001601936) (Filer) Filed: 2023-02-28 AccNo: 0001213900-23-015401 Size: 15 MB 网页链接查看全文
$Auris Medical(EARS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-038350 Act: 34 Size: 11 KB 网页链接
$Auris Medical(EARS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-037820 Act: 34 Size: 13 KB 网页链接
$Auris Medical(EARS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-032634 Act: 34 Size: 637 KB 网页链接
$Auris Medical(EARS)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-21-002228 Act: 33 Size: 2 KB 网页链接
$Auris Medical(EARS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-030677 Act: 34 Size: 320 KB 网页链接
$Auris Medical(EARS)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001213900-21-030525 Act: 33 Size: 210 KB 网页链接
$Auris Medical(EARS)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001213900-21-030402 Act: 33 Size: 210 KB 网页链接
$Auris Medical(EARS)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001213900-21-028265 Act: 34 Size: 47 KB 网页链接
$Auris Medical(EARS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-026712 Act: 34 Size: 13 KB 网页链接
$Auris Medical(EARS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-021901 Act: 34 Size: 497 KB 网页链接